BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2018
View Archived Issues
Japan AMED selects FunPep project for orphan drug support program
Read More
First subjects dosed in first-in-human study of TransCon CNP
Read More
Pfizer reports regulatory and pipeline highlights of first quarter 2018
Read More
Development of Wayshine Biopharm compounds advances for brain and lung cancer
Read More
Novel Ironwood soluble guanylate cyclase stimulator reduces neuroinflammation
Read More
AcelRx Pharmaceuticals resubmits Dsuvia NDA in U.S.
Read More
IGEM Therapeutics awarded grant from Innovate UK
Read More
Provention Bio acquires rights to teplizumab and MGD-010 from MacroGenics
Read More
Lipocine receives FDA complete response letter for Tlando
Read More
Novel NKCC1 inhibitor reduces brain damage after ischemic stroke in mice
Read More
Escient Pharmaceuticals launches to advance first-in-class GPCR-targeted drugs
Read More
Lodo Therapeutics and Genentech enter multi-target strategic collaboration
Read More
Syndax Pharmaceuticals describes preclinical activity of Menin/MLL1 inhibitor VTP-50469
Read More
Lundbeck updates pipeline progress of first quarter 2018
Read More
New EAAT3 inhibitors divulged by Roche
Read More
Regeneron presents novel REGN-4018 antibody for ovarian cancer
Read More
Novartis patents novel HBV HBsAg secretion inhibitors
Read More
CSIC, University of Glasgow present trypanosomal alternative oxidase inhibitors
Read More
Phase III study of Tecentriq and Cotellic in metastatic colorectal cancer misses primary endpoint
Read More
Forma Therapeutics collaborates with University of Oxford on deubiquitinating enzyme inhibitors
Read More
Astellas licenses rights to Aquinox's rosiptor in Japan and Asia-Pacific countries
Read More
MediciNova cleared to study ibudilast for glioblastoma
Read More
Sellas' galinpepimut-S awarded FDA orphan drug designation for multiple myeloma
Read More
FDA grants orphan drug designation to Cellectar's CLR-131 for rhabdomyosarcoma
Read More
YL Biologics and Kyowa submit Japanese NDA for etanercept biosimilar YLB-113
Read More
Gilead studies GS-9688 in virally suppressed patients with chronic HBV infection
Read More